Enanta Pharmaceuticals
ENTA
$12.07
Share price
-6.00%
Change (1 day)
-49.96%
Change (1 year)
Categories
Earnings for Enanta Pharmaceuticals (ENTA)
Earnings in 2023 (TTM): -$0.13 B
According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.13 B an increase over its 2021 earnings that were of -$0.13 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Enanta Pharmaceuticals from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.13 B | 5.89% |
| 2022 | -$0.13 B | -4.4% |
| 2021 | -$0.13 B | 91.12% |
| 2020 | -$66.81 M | -407.13% |
| 2019 | $21.75 M | -78.63% |
| 2018 | $0.10 B | 117.97% |
| 2017 | $46.7 M | -574.65% |
| 2016 | -$9.84 M | -110.83% |
| 2015 | $90.88 M | -4.5% |
| 2014 | $95.16 M | -638.53% |
| 2013 | -$17.68 M | -137.98% |
| 2012 | $46.52 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -18,088.68% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -8,374.81% | 🇨🇭 Switzerland |
 AbbVie ABBV | $7.53 B | -6,440.63% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $4.81 B | -4,150.67% | 🇺🇸 USA |
 Merck MRK | $5.11 B | -4,407.92% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 4,822.62% | 🇺🇸 USA |